RESEARCH LETTER
 
TOPICS
REFERENCES (15)
1.
Luo H, Wong J, Wong B. Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy. Cardiovasc Res 2010; 85: 347-56.
 
2.
Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA 2023; 329: 1098-113.
 
3.
Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021; 18: 169-93.
 
4.
Gigli M, Stolfo D, Merlo M, et al. Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine. Nat Rev Cardiol 2025; 22: 183-98.
 
5.
Harding D, Chong M, Lahoti N, et al. Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy. J Intern Med 2023; 293: 23-47.
 
6.
Lei Z, Cao J, Wu J, et al. Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy. ESC Heart Fail 2024; 11: 282-92.
 
7.
Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.
 
8.
Onyimba JA, Coronado MJ, Garton AE, et al. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biol Sex Differ 2011; 2: 2.
 
9.
Xiong C, Li B, Song R, et al. IFITM3 mediates inflammation-induced myocardial injury through JAK2/STAT3 signaling pathway. Mol Immunol 2024; 167: 1-15.
 
10.
Lemmens K, Doggen K, De Keulenaer GW. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 2007; 116: 954-60.
 
11.
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 2015; 12: 453-7.
 
12.
Hao J, Li W, Jiao W, et al. IL-17 affects the immune regulation of CD4+ T cells in dilated cardiomyopathy through JAK/STAT pathway. Cardiol Young 2025; 35: 16-23.
 
13.
Yasukawa H, Yajima T, Duplain H, et al. The suppressor of cytokine signaling-1 is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 2003; 111: 469-78.
 
14.
Luo Y, Zhang H, Yu J, et al. Stem cell factor/mast cell/CCL2/monocyte/macrophage axis promotes coxsackievirus B3 myocarditis and cardiac fibrosis by increasing Ly6C-high monocyte influx and fibrogenic mediator production. Immunology 2022; 167: 590-605.
 
15.
Sheng K, Ran Y, Feng X, et al. PTN secreted by cardiac fibroblasts promotes myocardial fibrosis and inflammation of pressure overload-induced hypertrophic cardiomyopathy through the PTN-SDC4 pathway. Life Sci 2025; 363: 123356.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top